1. Strategic Cooperation Achievements
Signed a Supply Agreement for High-end Peptide Intermediates with Pfizer Inc. (USA): Provided Fmoc-protected amino acids and peptide coupling intermediates for Pfizer's oncology drug production, with an annual supply volume of 1,500 tons and a contract value of 42 million US dollars. Becoming Pfizer's sole Asian supplier for this high-value category, the company's products meet USP Class 1 standards with peptide purity ≥ 99.9% and water content .2%, breaking the European and American monopoly.
Co-built a Pharmaceutical Intermediate R&D & Production Base in Singapore: Jointly invested 250 million US dollars with Singapore's Temasek Holdings to construct a 15,000-ton/year custom synthesis plant. Focusing on advanced intermediates for biologics and specialty drugs, the base will provide one-stop customization services for global pharmaceutical companies, with an expected annual sales volume exceeding 280 million US dollars after commissioning.
2. Export Scale Cases
Explosive Growth in Special Heterocyclic Intermediates Exports: Exported imidazole, pyrimidine and triazine derivatives to the EU, the Middle East and Japan, with an annual export volume of 10,000 tons and an export value of 280 million RMB, a year-on-year increase of 58%. The products meet ICH Q7 guidelines, accounting for 9% of Germany's specialty pharmaceutical intermediate market.
Full-scale Expansion in Latin American and Caribbean Markets: Exported beta-lactam intermediates and steroid intermediates to Brazil, Mexico, Cuba and other countries, with an annual export volume of 15,000 tons and an export value of 190 million RMB, a year-on-year growth of 68%. Among them, the market share in Brazil's API intermediate sector increased to 13%.
3. Market Breakthrough Cases
Breakthrough in North American Biopharmaceutical Intermediates: PEGylated intermediates (polyethylene glycol derivatives) obtained U.S. FDA DMF (Drug Master File) registration, entering the U.S. biologic drug production market with an annual export volume of 700 tons. The company became the only mainland Chinese supplier accessing North America's high-end biopharmaceutical intermediate market.
Upgraded Localized Technical Services in Europe: Established a technical support center in Frankfurt, Germany, providing process optimization, impurity control and regulatory compliance solutions for European pharmaceutical companies. This drove annual sales in the region to 85 million RMB with a customer repurchase rate of 94%.
Jun 13, 26
Analyzing Oxandrolone Side Effects and Selective Peptides
Understanding the nuances of pharmaceutical interactions and potential oxandrolone side effects is critical for researchers and clinicians aiming to optimize patient outcomes in metabolic and cardiovascular studies. While many chemical compounds offer profound therapeutic potential, the ability to distinguish between intended biological activity and adverse reactions ensures a higher standard of safety and efficacy in translational medicine. On a global scale, the demand for high-purity research peptides and active pharmaceutical ingredients has surged as scientific communities seek to mitigate the risks associated with legacy treatments.
Jun 12, 26
Clinical Guide to Oxandrolone Uses and Metabolic Benefits
In the contemporary landscape of metabolic medicine and pharmaceutical research, understanding the diverse oxandrolone uses is pivotal for clinicians and researchers alike. While the industry continues to evolve, the demand for high-purity active pharmaceutical ingredients APIs remains the cornerstone of effective therapeutic outcomes, particularly in treating muscle wasting and metabolic dysfunction. The global shift toward personalized medicine has highlighted the importance of specific androgenic agents and GLP-1 agonists in managing complex patient profiles. By analyzing the systemic impact of these compounds, the pharmaceutical sector can better address the needs of patients recovering from severe trauma or managing chronic endocrine imbalances.
Jun 11, 26
Salmon Calcitonin and oxandrolone use for Bone Health
The global pharmaceutical landscape is increasingly focusing on the precision of bone metabolism regulation, where the strategic oxandrolone use is often discussed in the context of anabolic recovery, yet the specialized application of Salmon Calcitonin provides a critical alternative for systemic calcium management. Understanding the nuanced differences between anabolic agents and calcitonin-based therapies is essential for healthcare providers aiming to treat severe osteoporosis and hypercalcemia. In the realm of chemical raw material manufacturing, the production of high-purity peptides like Salmon Calcitonin represents a pinnacle of biotechnological achievement. While some research focuses on oxandrolone use for muscle wasting, Salmon Calcitonin targets the osteoclast directly,
Contact Us
Professional Chemical Supply, Efficient Service
Subscribe For Newsletter!
Your Email...
